Skip to content

Bharangyadi and Kaliphal in Asthma

A Clinical evaluation of Bharangyadi kwath and Kaliphal churna in the management of Tamak Shwasa with special reference to Bronchial Asthma - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107695
Enrollment
50
Registered
2026-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

None listed

Sponsors

Dr Hement Kumar Singh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient having age between 20 years to 60 years of either sex. 2.Patients present with classical clinical Tamak shwasa. symptoms irrespective of gender,caste,occupation and economic status attending the O.P.D. or I.P.D. of attached hospitals of Shri Dhanwantari Ayurvedic Medical College And Research Centre,Mathura U.P. 3.Chronicity - less than 5 years. 4.Presence of Pratyatma Lakshanas of Tamak shwasa. 5.Peak flow meter Rate more than 80Lit/min & less than 300Lit/min

Exclusion criteria

Exclusion criteria: 1.Patients below 20 years and above 60 years of age. 2.Asthma in pregnancy. 3. Peak flow meter Rate less than 80Lit/min are excluded. 4.Patients with history of Tamak shwasa more than 5 years 5.Occupational Asthma. 6.Emergency condition of the patient, who requires oxygen inhalation 7.Patients not willing to give informed consent for the trial.

Design outcomes

Primary

MeasureTime frame
1.Improvement in Peak Expiratory Flow Rate (PEFR) 2.Change in Rhonchi or Crepitations on AuscultationTimepoint: -Baseline (0day) -follow up at 15 day -follow up at 30 day -follow up at 45 day -follow up at 60 day

Secondary

MeasureTime frame
-Change in frequency of asthma attacks. -Change in duration of asthma attacks. -Change in dyspnoea severity score. -Change in cough severity score. -Change in sputum production score. -Change in wheezing score. -Change in associated symptoms score(Peenasa, chest pain). Timepoint: -Baseline (0day) -follow up at 15 day -follow up at 30 day -follow up at 45 day -follow up at 60 day

Countries

India

Contacts

Public ContactDr Megha Dixit

Shri Dhanwantri Ayurvedic Medical College and Research Centre

drmeghadixit90@gmail.com9671821339

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026